T-RAFIC Training network for tracking and controlling therapeutic immune cells in cancer
- Coordinator
- Ludwig-Maximilians-Universitaet Muenchen, Germany
- Runs
- 1 March 2025 to 28 February 2029
- Status
- Running
- EU funding
- €4.1m
- Total cost
- —
- Partners
- 28 organisations in 9 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101168810
What the project is doing
In the project's own words, from its summary on CORDIS.
Cancer immunotherapies have been established in a growing number of clinical indications and the pace of development is massively accelerating. Currently over 6.000 clinical trials are investigating immune-related treatments in oncology especially in combinations. It includes both adoptive cellular therapies and immune modulating treatments like immune check point blockade. In contrast, the understanding of how such therapies mediate their mode of action is still mostly poorly understood.
In particular, the role of distribution and relocation of immune cells after therapeutic interventions remains unknown. This is surprising, as immune cell interactions are a hallmark of therapeutic immune responses. T-RAFIC will enhance understanding of immune cell trafficking under therapeutic influence. It will open new paths and avenues to treatments, boost their efficacy and help prioritizing the plethora of immune therapeutic combinations.
In the past, detailed analysis of cellular distributions was facing technical barriers. Advances in technologies, now permit tracking and visualization of cells in vitro and in vivo at an unprecedented resolution, allowing for the first time studies on immune cells under therapeutic influence. This emerging field of research has enormous potential and key importance for next generation of researchers in oncology and beyond.
However, experts in this field are missing and this threats European research, development and medicine. Therefore, T-RAFIC joins forces of 19 academic and three industrial partners from nine European countries to conduct an innovative and interdisciplinary approach combining cell imaging with bioinformatics, cell engineering and clinician expertise. The network bundles recognised expertise in cancer immunotherapies, empowering European research and innovation and ensuring a sustainable cooperation in science and training.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Ludwig-Maximilians-Universitaet Muenchen | Planegg | Germany | Coordinator |
| Medizinische Universitat Innsbruck | Innsbruck | Austria | Participant |
| ViraTherapeutics GmbH | Innsbruck | Austria | Associatedpartner |
| Fondazione per L'istituto Di Ricerca in Biomedicina | Bellinzona | Switzerland | Associatedpartner |
| InCephalo AG | Allschwil | Switzerland | Associatedpartner |
| Roche Glycart AG | Schlieren | Switzerland | Associatedpartner |
| Universita Della Svizzera Italiana | Lugano | Switzerland | Associatedpartner |
| Universitat Zurich | Zurich | Switzerland | Associatedpartner |
| Klinikum Der Ludwig-Maximilians-Universitat Munchen | Munchen | Germany | Associatedpartner |
| Klinikum Der Technischen Universität München (tum Klinikum) | Muenchen | Germany | Participant |
| Miltenyi Biotec BV & Co Kg | Bergisch Gladbach | Germany | Participant |
| Technische Universitaet Muenchen | Muenchen | Germany | Associatedpartner |
| Danmarks Tekniske Universitet | Kongens Lyngby | Denmark | Participant |
| Kobenhavns Universitet | Kobenhavn | Denmark | Associatedpartner |
| Region Hovedstaden | Hillerod | Denmark | Participant |
| Institut Gustave Roussy | Villejuif | France | Participant |
| Institut National De La Sante Et De La Recherche Medicale | Paris | France | Participant |
| Universite De Rennes | Rennes | France | Associatedpartner |
| Universite Paris Cite | Paris | France | Associatedpartner |
| Universite Paris-Saclay | Gif-Sur-Yvette | France | Associatedpartner |
| Universita Humanitas | Pieve Emanuele | Italy | Participant |
| Stichting Amsterdam Umc | Amsterdam | Netherlands | Participant |
| Vereniging Voor Christelijk Hoger Onderwijs Wetenschappelijk Onderzoek En Patientenzorg | Amsterdam | Netherlands | Associatedpartner |
| Oslo Universitetssykehus Hf | Oslo | Norway | Participant |
| Universitetet I Oslo | Oslo | Norway | Associatedpartner |
| Anglia Ruskin University | Chelmsford | United Kingdom | Associatedpartner |
| Intelligent Omics Limited | Nottingham | United Kingdom | Associatedpartner |
| The Nottingham Trent University | Nottingham | United Kingdom | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI